Yes, breast cancer can come back after treatment in some people, but recurrence is not inevitable. The individual risk varies substantially according to the original stage, tumour size, lymph node involvement, tumour grade, biological subtype, response to treatment and other factors. [1]
Recurrence can happen months or years after treatment. Many recurrences occur during the first several years, but some breast cancers, particularly hormone receptor-positive disease, can recur much later. [1] [5]
Breast cancer recurrence means breast cancer has returned after the initial treatment and a period during which there was no detectable disease.
Recurrence can occur when a very small number of cancer cells survive treatment but remain too small to detect. These cells may later begin growing again. [1]
This does not automatically mean the original treatment was incorrect or ineffective. Treatment can greatly reduce recurrence risk without being able to reduce that risk to zero in every patient.
| Type | What it means |
|---|---|
| Local recurrence | Cancer returns in the breast, chest wall or surgical area. |
| Regional recurrence | Cancer returns in nearby lymph nodes, such as those under the arm, near the collarbone or in the neck. |
| Distant recurrence | Breast cancer returns in a distant organ and is considered metastatic breast cancer. |
Common sites of distant recurrence include the bones, lungs, liver and brain. [1]
No.
A person who has previously had breast cancer can later develop a completely new breast cancer known as a second primary breast cancer.
This is biologically separate from a recurrence of the first tumour. [1]
A new tumour therefore needs appropriate imaging, biopsy and biomarker testing rather than simply being assumed to be the original cancer returning.
Yes.
After a mastectomy, local recurrence can occur in the skin, surgical scar or chest wall. Cancer can also recur in nearby lymph nodes or distant organs. [1]
Mastectomy and other treatments reduce recurrence risk substantially, but they cannot guarantee that every microscopic cancer cell has been eliminated.
There is no single time period that applies to all breast cancers.
Many recurrences occur during the first few years after treatment, but breast cancer can also recur many years later. [1]
No.
For hormone receptor-positive breast cancer, studies have shown an ongoing risk of distant recurrence from 5 to 20 years after diagnosis in some patients. The level of risk depends on factors such as the original tumour size and lymph node involvement. [5]
Recurrence risk in TNBC is more concentrated during the first five years after diagnosis and tends to decline substantially afterward. [6]
The early recurrence risk is often lower than in hormone receptor-negative disease, but the risk can persist for much longer and late recurrence may occur more than 10 years after diagnosis. [5]
TNBC does not inevitably return within five years, and hormone-positive breast cancer does not inevitably return later.
Learn more: Triple-Negative Breast Cancer: Is It More Aggressive and How Is It Treated?.
Possible signs include:
Symptoms depend on where the cancer is located and can include:
Contact your care team if you notice a new lump, an unusual change around the surgical area, unexplained symptoms that persist or worsen, or any other new health change that clearly differs from your usual state.
You do not need to wait for the next routine follow-up appointment if a concerning symptom develops.
Recurrence risk is individualized, but factors associated with a higher risk include:
No strategy can guarantee that recurrence will never occur, but much of breast cancer treatment is specifically designed to reduce this risk.
Depending on the cancer, this can include surgery, radiation, chemotherapy, endocrine therapy, HER2-targeted therapy, immunotherapy and other systemic treatments.
Taking prescribed long-term treatment as recommended and discussing side effects rather than stopping treatment without medical advice can also be important.
Physical activity and maintaining a healthy weight are also associated with better breast cancer outcomes. [1]
For more on treatment decisions: Breast Cancer Treatment: How Does the Plan Change by Stage and Subtype?.
Follow-up is individualized, but may include:
Most experts recommend a mammogram of the treated breast around 6 to 12 months after surgery and radiation are completed, followed by mammography at least annually according to the care plan. [3]
Routine mammography is usually no longer needed on the side where the entire breast was removed, while the remaining breast continues to need regular mammograms. [3]
Routine mammograms are generally not required because there is usually not enough breast tissue left to screen, although clinical follow-up remains important.
Usually not after curative treatment for stage I–III breast cancer if you have no symptoms or abnormal findings.
Randomized studies have not shown that routinely performing body imaging or certain blood tests in asymptomatic survivors improves survival or quality of life compared with standard clinical follow-up. [4]
ASCO also advises against routine surveillance imaging such as PET, CT and radionuclide bone scans, or routine serum tumour markers, in asymptomatic people treated for breast cancer with curative intent. [7]
For most survivors of early breast cancer without symptoms, clinical follow-up and appropriate breast imaging are the foundation. Additional scans are ordered when there is a medical reason.
If a new symptom or abnormal finding appears, recurrence should not be assumed without further evaluation.
Depending on the situation, tests can include:
When possible, recurrent disease is biopsied and biomarkers such as ER, PR and HER2 may be reassessed because they can differ from those of the original tumour and can affect treatment. [4]
Not necessarily.
The initial treatment may have removed or destroyed all cancer that could be detected and substantially reduced recurrence risk, while a very small number of microscopic cells remained undetectable.
Those cells may remain dormant before growing again later.
Yes. Treatment depends on whether recurrence is local, regional or distant, the tumour's current biomarkers and previous treatments.
Treatment may include surgery, radiation and systemic therapy. Some patients with locoregional recurrence can achieve long-term disease control with appropriate treatment. [1] [4]
Distant recurrence is metastatic breast cancer. Systemic treatment is usually central, with the goals of controlling disease, slowing progression, relieving symptoms and maintaining quality of life.
Treatment selection can depend on ER, PR, HER2, molecular findings, the location of metastases, previous treatments and the interval between initial therapy and recurrence.
For more context on prognosis: Breast Cancer Survival Rates by Stage and Type.
It can recur in some people after a period with no detectable disease, but many people treated for breast cancer never develop a recurrence.
Yes. It can recur in the chest wall or surgical area, nearby lymph nodes or distant organs, although mastectomy and additional treatments substantially reduce risk.
Yes, particularly some hormone receptor-positive breast cancers, which can have a risk of late recurrence. [5]
Yes. Late recurrence more than 10 years after diagnosis can occur, especially in hormone receptor-positive disease.
There is no single first symptom. A new breast or chest wall lump may signal local recurrence, while distant recurrence can cause symptoms that depend on the affected organ.
No. Bone pain has many common causes. New unexplained pain that persists or worsens should be assessed rather than assumed to be cancer.
Not routinely for most asymptomatic people treated for early breast cancer. Advanced imaging is usually used when symptoms, examination findings or another medical reason justify it. [4] [7]
Yes. Local and regional recurrences may be treated with additional local and systemic therapy, while metastatic recurrence has multiple treatment options that can control disease for varying periods of time.
Breast cancer can come back after treatment, but recurrence is not inevitable. Risk depends on the original stage, lymph nodes, tumour biology, grade, response to treatment and other individual factors.
Recurrence may be local, regional or distant. A later breast tumour can also be a completely new primary breast cancer rather than recurrence of the first cancer.
Common symptoms such as headaches, fatigue, cough or bone pain usually have causes other than cancer, but new, unexplained or persistent symptoms deserve medical assessment.
For most asymptomatic survivors of early-stage breast cancer, follow-up does not require routine PET, CT or tumour-marker testing. Clinical follow-up and appropriate mammography remain central, with additional tests used when there is a clear medical reason.